Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fechner J et al. – Fospropofol was well tolerated in the first two clinical studies and no serious side effects were reported. After characterization of the true pharmacokinetic/pharmacodynamics profile, fospropofol, an aqueous solution, has the potential to favorably compare with benzodiazepines for procedural sedation and also may be used for long–term sedation and intravenous anesthesia.

Related Articles

A comparison between target-controlled and manually controlled propofol infusions in patients undergoing routine surgical procedures
European Journal of Anaesthesiology, 10/15/09    Relevance Score: 92%

Prevention Of Propofol Injection Pain With Small-Dose Ketamine
Middle East Journal of Anesthesiology, 10/08/09    Relevance Score: 91%

Early Cognitive Impairment After Sedation for Colonoscopy: The Effect of Adding Midazolam and/or Fentanyl to Propofol
Anesthesia & Analgesia, 10/21/09    Relevance Score: 87%

Propofol for Terminal Sedation in Palliative Care: A Systematic Review
Journal of Palliative Medicine, 10/20/09    Relevance Score: 87%

Oxygenation During One-Lung Ventilation With Propofol Or Sevoflurane
Middle East Journal of Anesthesiology, 10/08/09    Relevance Score: 87%

Today in Other Drugs...keeping you current

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Current Medical Research and Opinion, 11/25/09

Anti-relapse medications: Preclinical models for drug addiction treatment
Pharmacology & Therapeutics, 11/25/09

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address